![Igor Matushansky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Igor Matushansky
Directeur/Membre du Conseil chez Crescendo Biologics Ltd.
Postes actifs de Igor Matushansky
Sociétés | Poste | Début | Fin |
---|---|---|---|
Crescendo Biologics Ltd.
![]() Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 02/07/2018 | - |
The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - | - |
Historique de carrière de Igor Matushansky
Anciens postes connus de Igor Matushansky
Sociétés | Poste | Début | Fin |
---|---|---|---|
HOOKIPA PHARMA INC. | Directeur Technique/Scientifique/R&D | 01/03/2017 | 30/06/2022 |
Daiichi Sankyo, Inc.
![]() Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 01/01/2015 | 01/01/2017 |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2012 | 01/01/2015 |
Columbia University Medical Center | Corporate Officer/Principal | 01/01/2007 | 01/01/2012 |
Formation de Igor Matushansky
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
HOOKIPA PHARMA INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Crescendo Biologics Ltd.
![]() Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Daiichi Sankyo, Inc.
![]() Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Igor Matushansky
- Expérience